News

Rheumatoid arthritis patients treated with mavrilimumab had significantly reduced disease activity and greater ARC20 response compared to placebo in phase IIB study.

Two doses of sirukumab, compared with placebo, improves the signs and symptoms of patients with active rheumatoid arthritis, researchers report.

MRI measures appear to be on target with patient-reported outcomes in rheumatoid arthritis, researchers report in ARD.

Schizophrenia and rheumatoid arthritis appear to have a DNA level connection.

A new study finds that vitamin D supplementation is associated with lower rates of acute respiratory tract infections, especially in people who are vitamin D deficient.

For systemic lupus erythematosus patients prescribed glucocorticosteroids, mortality has been found to be more frequent than in patients not prescribed glucocorticosteroids, researchers say.

Despite good responses, patients dropped adalimumab treatment.

Patients who didn't respond to methotrexate may do well on baricitinib.

Researchers evaluated children with arthritis, uveitis, and both.

Facing a growing shortage, rheumatology is looking to attract the next generation of providers.

The U.S. Food and Drug Administration has approved brodalumab (Siliq) for the treatment of adults and moderate-to-severe plaque psoriasis.

Patient-reported outcomes are in line with clinical trial results for baricitinib, an international research team reports.

The 23-valent pneumococcal polysaccharide vaccine (PPSV23) does not prevent pneumonia in rheumatoid arthritis patients, a new study finds.

Brain changes that occur as a result of small vessel disease negatively effect gait in senior patients, research shows.

Advanced techniques allowed researchers to isolate T-cells involved in RA.

For gout patients with suboptimal responses to allopurinol, adding lesinurad may significantly reduce serum urate levels.

Biologics dose individualization should be used more often in clinical practice due to its direct benefit for patients with rheumatoid arthritis, researchers recommend.

There are few tests to accurately assess the degree and effects of lupus in children, but Ped-ANAM proves to be a promising option.

Lupus patients who receive healthcare at more than one location face a greater risk of infection and comorbidities, research shows.

When inflammatory arthritis develops in the context of Lyme disease, clinicians have three options, experts say.

Approximately one percent of the general population carries the auto-antibodies associated with rheumatoid arthritis, a new study shows.

A foot or ankle injury misdiagnosis can lead to chronic pain or arthritis.

A higher initial dose of methotrexate is not always associated with better clinical outcomes for newly diagnosed rheumatoid arthritis patients, a study shows.

Anti-inflammatory treatment in rheumatoid arthritis patients, especially with infliximab added to methotrexate, improves HDL function and may potentially reduce cardiovascular risk, a study shows.

RA patients with low disease activity in the first trimester of pregnancy, are likely to have low disease activity or reach remission by the third trimester.

Rheumatologists are likely to encounter a wide variety of immune-related adverse events as use of immune checkpoint inhibitors expands.

The association between periodontal disease and rheumatoid arthritis has been well established in studies, but now researchers describe a mechanism that could explain this association.

Over-the-counter treatment for joint pain commonly prescribed by physicians may increase intraocular pressure leading to glaucoma risk, new study suggests.

Patients with inflammatory arthritis are being treated for cardiovascular risk factors at rates similar to that of the general population, even though their risk is higher, study shows.

Clinical enthesitis is a common condition for some psoriatic arthritis patients who are disproportionately affected by inflammation, particularly of the Achilles tendon, plantar fascia and lateral epicondyle.